MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 102 filers reported holding MAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $21,059 | -10.9% | 5,026 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $23,622 | +50.6% | 5,026 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $15,681 | -32.0% | 5,026 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $23,069 | -7.3% | 5,026 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,879 | -32.4% | 5,026 | -25.4% | 0.00% | -50.0% |
| Q4 2022 | $36,795 | -16.0% | 6,739 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $43,804 | +37.4% | 6,739 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $31,875 | -32.3% | 6,739 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $47,106 | -82.7% | 6,739 | -74.8% | 0.00% | -50.0% |
| Q4 2021 | $272,593 | – | 26,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |